Cargando…

Association of OCT biomarkers and visual impairment in patients with diabetic macular oedema with vitreomacular adhesion

BACKGROUND: To analyse the distribution of spectral domain optical coherence tomography (SD-OCT) biomarkers in different types of vitreomacular adhesion (VMA) associated visual impairment in diabetic macular oedema. METHODS: A total of 317 eyes of 202 patients were enrolled. Cases were divided into...

Descripción completa

Detalles Bibliográficos
Autores principales:	Subramanian, Brughanya, Devishamani, Chitralekha, Raman, Rajiv, Ratra, Dhanashree
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353796/ https://www.ncbi.nlm.nih.gov/pubmed/37463157 http://dx.doi.org/10.1371/journal.pone.0288879

Ejemplares similares

Narrative review of artificial intelligence in diabetic macular edema: Diagnosis and predicting treatment response using optical coherence tomography
por: Chakroborty, Sandipan, et al.
Publicado: (2021)

Vitreomacular interface abnormalities in patients with diabetic macular oedema and their implications on the response to anti-VEGF therapy
por: Mikhail, Michael, et al.
Publicado: (2018)

Effects of Vitreomacular Adhesion on Age-Related Macular Degeneration
por: Kang, Eui Chun, et al.
Publicado: (2015)

OCT proves that vitreomacular adhesion is significantly more likely to develop vision-threatening retinal complications than vitreomacular separation
por: Liao, Ding-Ying, et al.
Publicado: (2020)

Indicators of Visual Prognosis in Diabetic Macular Oedema
por: Sen, Sagnik, et al.
Publicado: (2021)

OCT-guided Hyaloid Release for Vitreomacular Traction Syndrome
por: Chung, Eun Jee, et al.
Publicado: (2008)

Commentary: Switching of anti-vascular endothelial growth factor agents in refractory diabetic macular edema
por: Ratra, Dhanashree
Publicado: (2021)

Visual function response to ocriplasmin for the treatment of vitreomacular traction and macular hole
por: Jackson, Timothy L., et al.
Publicado: (2017)

PATIENT-REPORTED VISUAL FUNCTION FROM THE OCRIPLASMIN FOR TREATMENT FOR SYMPTOMATIC VITREOMACULAR ADHESION, INCLUDING MACULAR HOLE (OASIS) STUDY
por: Mein, Calvin, et al.
Publicado: (2020)

Surgery for macular holes associated with unusual concomitant pathologies
por: Ratra, Dhanashree, et al.
Publicado: (2013)

The effect of vitreomacular adhesion in exudative age-related macular degeneration on the results of ranibizumab intravitreal injection
por: Suzuki, Hiroyuki, et al.
Publicado: (2017)

Redesigning services for the management of vitreomacular traction and macular hole
por: Amoaku, W, et al.
Publicado: (2014)

Apparent double macular hole caused by vitreomacular traction
por: Babu, Naresh, et al.
Publicado: (2020)

Cell composition at the vitreomacular interface in traumatic macular holes
por: Guenther, Stefanie R., et al.
Publicado: (2021)

Surgical Outcome of Vitreomacular Traction Associated With Macular Hole
por: Tayyab, Mashal, et al.
Publicado: (2022)

Spontaneous Resolution of Vitreomacular Traction in Two Patients with Diabetic Macular Edema
por: Almeida, David R.P., et al.
Publicado: (2014)

Vitreomacular interface after anti-VEGF injections in diabetic macular edema
por: Veloso, Carlos E., et al.
Publicado: (2021)

Visual rehabilitation using video game stimulation for Stargardt disease
por: Ratra, Dhanashree, et al.
Publicado: (2019)

Effect of vitreomacular adhesion and vitreous gel on age-related reduction of macular thickness: a retrospective observational study
por: Kumagai, Kazuyuki, et al.
Publicado: (2016)

Profile of ocriplasmin and its potential in the treatment of vitreomacular adhesion
por: Stefanini, Francisco R, et al.
Publicado: (2014)

A Review of Current Management of Vitreomacular Traction and Macular Hole
por: García-Layana, Alfredo, et al.
Publicado: (2015)

Cost-effectiveness of ocriplasmin for the treatment of vitreomacular traction and macular hole
por: Bennison, Craig, et al.
Publicado: (2016)

An Assessment of Vitreous Degeneration in Eyes with Vitreomacular Traction and Macular Holes
por: Ghadiali, Quraish, et al.
Publicado: (2017)

Incidence and prevalence of vitreomacular traction with and without macular hole in Germany
por: Menzler, Jacob, et al.
Publicado: (2019)

Preliminary Report on Optical Coherence Tomography Angiography Biomarkers in Non-Responders and Responders to Intravitreal Anti-VEGF Injection for Diabetic Macular Oedema
por: Chouhan, Sanjana, et al.
Publicado: (2023)

Choroidal structural analysis in eyes with diabetic retinopathy and diabetic macular edema—A novel OCT based imaging biomarker
por: Gupta, Chanda, et al.
Publicado: (2018)

Action on diabetic macular oedema: achieving optimal patient management in treating visual impairment due to diabetic eye disease
por: Gale, R, et al.
Publicado: (2017)

Cost-effectiveness of ranibizumab in treatment of diabetic macular oedema (DME) causing visual impairment: evidence from the RESTORE trial
por: Mitchell, Paul, et al.
Publicado: (2012)

Impact of metabolic control on macular thickness in diabetic macular oedema
por: Peng, Yi-Jie, et al.
Publicado: (2017)

A multifocal electroretinography study to evaluate risk of developing macular hole in the fellow eye of patients suffering with unilateral macular hole
por: Dalan, Daleena, et al.
Publicado: (2020)

Emerging nonsurgical methods for the treatment of vitreomacular adhesion: a review
por: Schneider, Eric W, et al.
Publicado: (2011)

Clinical Features of Vitreomacular Traction Syndrome with Peripheral Vitreoretinal Adhesion
por: Fukumoto, Masanori, et al.
Publicado: (2020)

Diabetic Macular Oedema Guidelines: An Australian Perspective
por: Yuen, Yew Sen, et al.
Publicado: (2023)

OCT biomarkers as predictors of visual improvement in diabetic macular edema eyes receiving dexamethasone implants
por: Visioli, Giacomo, et al.
Publicado: (2023)

The Vitreomacular Interface in Diabetic Retinopathy
por: Agarwal, Daniel, et al.
Publicado: (2015)

Early vitreomacular separation with delayed macular hole closure after ocriplasmin treatment
por: Liang, I-Chia, et al.
Publicado: (2016)

Ocriplasmin for symptomatic vitreomacular adhesion: an evidence-based review of its potential
por: Song, Su Jeong, et al.
Publicado: (2014)

Efficacy of deep learning-based artificial intelligence models in screening and referring patients with diabetic retinopathy and glaucoma
por: Surya, Janani, et al.
Publicado: (2023)

Clinically meaningful visual improvements and predictors of early vision gains with ranibizumab for diabetic macular oedema
por: Morse, Lawrence, et al.
Publicado: (2019)

Commentary: Retinal branch vein occlusion and arteriosclerosis: Can cardio-ankle vascular index be a useful biomarker?
por: Kaushal, Anshu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6cgp9ulvqgat8ai7at5dea569o